The future of pharmocotherapy for paediatric anxiety

Robert L. Findling

Research output: Contribution to journalArticlepeer-review

Abstract

There is a growing body of data supporting the use of pharmacological agents in the treatment of paediatric anxiety. The most compelling data exists for the use of selective serotonin re-uptake inhibitors. However, questions the safe and efficacious use of medications with anxiolytic properties still remain. Although the field has progressed in the past several years, it is evident that more research needs to be done in the future.

Original languageEnglish (US)
Pages (from-to)573-574
Number of pages2
JournalExpert opinion on pharmacotherapy
Volume3
Issue number5
DOIs
StatePublished - May 27 2002
Externally publishedYes

Keywords

  • Adolescent
  • Anxiety
  • Child
  • Psychopharmacology
  • Treatment

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'The future of pharmocotherapy for paediatric anxiety'. Together they form a unique fingerprint.

Cite this